Factors associated with serum HCV RNA positivity in anti-HCV antibody positive intravenous drug users

Journal of Clinical Epidemiology

Volumn 51, Issue 5, 1998, Pages 423-427

  Pirisi, Mario ^a   Toniutto, Pierluigi ^a   Fabris, Carlo ^a   Lombardelli, Tiziana ^a   Falleti, Edmondo ^a   Tisminetzky, Sergio G ^b   Baralle, Francisco ^b   Bartoli, Ettore ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Alcohol; Hepatitis C virus; Infection; Intravenous drug users; Life styles; Liver disease

Indexed keywords

VIRUS RNA;

ACUTE HEPATITIS; ADULT; ALCOHOL ABUSE; ARTICLE; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; LIFESTYLE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTITUTION;

ADULT; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER FUNCTION TESTS; MALE; POLYMERASE CHAIN REACTION; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL LOAD;

EID: 0031954620     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(97)00305-3     Document Type: Article

References (25)

1. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
2. Rakela J., Redeker A.G. Chronic liver disease after acute and chronic non-A, non-B viral hepatitis. Gastroenterology. 77:1979;1200-1202.
3. Alter M.J. Epidemiology of hepatitis C in the West. Semin Liver Dis. 15:1995;5-14.
4. Cherubin C.E., Sapira J.D. The medical complications of drug addiction and the medical assessment of the intravenous drug user. 25 years later Ann Intern Med. 119:1993;1017-1028.
5. Verbaan H., Andersson K., Eriksson S. Intravenous drug abuse - the major route of hepatitis C virus transmission among alcohol-dependent individuals? Scand J Gastroenterol. 28:1993;714-718.
6. Oshita M., Hayashi N., Kasahara Aet al. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology. 20:1994;1115-1120.
7. Fong T-L, Kanel G.C., Conrad A., Valinluck B., Charbonfau F., Adkins R.H. Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology. 19:1994;554-557.
8. Toniutto P., Pirisi M., Tisminetzky SGet al. Discordant results from hepatitis C virus genotyping by procedures based on amplification of different genomic regions. J Clin Microbiol. 34:1996;2382-2385.
9. McHutchison J.G., Person J.L., Govindarajan Set al. Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology. 15:1992;19-25.
10. Gordon S.C., Elloway R.S., Long J.C., Dmuchowski C.F. The pathology of hepatitis C as a function of mode of transmission. Blood transfusion vs. intravenous drug use Hepatology. 18:1993;1338-1343.
11. Seef L.B., Buskell-Bales Z., Wright E.C., Durako S.J., Alter H.J., Iber F.L. Long-term mortality after transfusion-associated Non-A, Non-B hepatitis. N Engl J Med. 327:1992;1906-1911.
12. Koretz R.L., Abbey H., Coleman E., Gitnick G. Non-A, Non-B post-transfusion hepatitis. Looking back in the second decade. Ann Intern Med. 119:1993;110-115.
13. Simmonds P., Zhang L.Q., Watson HGet al. Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. Lancet. 336:1990;1469-1472.
14. McGuinness P.H., Bishop G.A., Lien A., Wiley B., Parsons C., McCaughan G.W. Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors. Hepatology. 18:1993;485-490.
15. Marin M.G., Bresciani S., Puoti Met al. Clinical significance of serum hepatitis C virus (HCV) RNA as a marker of HCV infection. J Clin Microbiol. 32:1994;3008-3012.
16. Pawlotsky J-M, Tsakiris L., Roudot-Thoraval Fet al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis. 171:1995;1607-1610.
17. Silini E., Bono F., Cividini Aet al. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol. 22:1995;691-695.
18. Silini E., Bono F., Cividini Aet al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology. 21:1995;285-290.
19. Naito M., Hayashi N., Hagiwara Het al. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology. 19:1994;871-875.
20. Kato N., Yokosuka O., Hosoda K., Ito Y., Ohto M., Omata M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction. Increase of the virus in advanced liver disease Hepatology. 18:1993;16-20.
21. Gretch D., Corey L., Wilson Jet al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction. High-titer viremia correlates with advanced stage of disease J Infect Dis. 169:1994;1219-1225.
22. Yousuf M., Nakano Y., Tanaka E., Sodeyama T., Kiyosawa K. Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up. Scand J Gastroenterol. 27:1992;812-816.
23. Lau J.Y.N., Davis G.L., Kniffen Jet al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 341:1993;1501-1504.
24. Tor J., Llibre J.M., Carbonell Met al. Sexual transmission of hepatitis C virus and its relationship with hepatitis B virus and HIV. BMJ. 301:1990;1130-1133.
25. François M., Roingeard P., Dubois F., Bacq Y., Goudeau A., Barin F. Lower serum hepatitis C virus RNA titers in patients with concurrent chronic hepatitis B virus infection. J Infect Dis. 169:1994;1411-1412.